drugset / Trial / NCT06358586
New Paediatric Formulation of Tachipirina®
NaSingle-groupOpen-labelOther
Summary
This is a single centre, single dose, single-arm, open-label, palatability study. The aim of the present study is to investigate the palatability of the newly developed Tachipirina® 120 mg/5 mL oral suspension with strawberry flavour. The study will be conducted in paediatric volunteers that represent the target population for this product.
Timeline
- Start
- 2022-04-09
- Primary completion
- 2022-04-25
- Completion
- 2022-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tachipirina® | Unknown | 10 ml | Oral |
Indications
No indication recorded.